miRNA
Completed
28 enrolled
AYAConnect
Phase NA Completed
63 enrolled
EARN
Phase NA Completed
33 enrolled
TESTPET
Completed
10 enrolled
Financial Toxicity and Quality of Life in Patients With TGCT
Completed
24 enrolled
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
Phase 1 Completed
25 enrolled
Testicular Self-Examination Awareness in Young Men
Phase NA Completed
120 enrolled
High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors
Phase 2 Completed
64 enrolled 10 charts
Short-term Testosterone Replacement in Testicular Cancer Survivors
Phase 2 Completed
32 enrolled
Vascular Fingerprint Validation Study
Completed
101 enrolled
Mental Health of Men Before and After Testicular Cancer Treatment
Completed
29 enrolled
Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study
Completed
38 enrolled
Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity
Completed
173 enrolled
TASTY
Phase 4 Completed
140 enrolled
GAMEC-II
Phase 2 Completed
36 enrolled
Early Rehabilitation of Cancer Patients
Phase NA Completed
300 enrolled
Testicular Self-examination Training Given to Students
Phase NA Completed
100 enrolled
CATCHER
Phase NA Completed
154 enrolled
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Phase 1/2 Completed
58 enrolled 24 charts
Effect of Online Education Given to Young Adults on Testicular Cancer Health Beliefs and Behaviors
Phase NA Completed
90 enrolled
TANNED
Completed
17 enrolled
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
Phase 2 Completed
23 enrolled 11 charts
The Impact of the COVID-19 Pandemic on Testicular Cancer
Completed
50 enrolled
TENY
Phase NA Completed
90 enrolled
The Effect of the Brochure on Testicular Self-Exam
Phase NA Completed
92 enrolled
Flipped Learning Model on Students' Knowledge and Health Beliefs
Phase NA Completed
66 enrolled
Pazotest-01
Phase 2 Completed
43 enrolled
Malignant Testicular Tumors in Children: A Single Institution's 12-year Experience
Completed
42 enrolled
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
Phase 2 Completed
304 enrolled 12 charts
Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors
Phase 3 Completed
280 enrolled
G3 RPLN PBC
Completed
1,135 enrolled
Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors
Phase 1 Completed
14 enrolled
Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Phase NA Completed
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
The Platinum Study Comparison Group
Completed
102 enrolled
Testosterone, Cognition, Ageing, and Cancer
Completed
133 enrolled
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
Phase 1 Completed
21 enrolled
INTELLECT
Completed
37 enrolled
VECTOR
Completed
36 enrolled
EPAC
Phase NA Completed
213 enrolled 20 charts
ALCeP
Phase 2/3 Completed
56 enrolled
Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer
Phase 2 Completed
11 enrolled
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
Phase 1 Completed
70 enrolled
Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors
Phase 2 Completed
9 enrolled
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
Phase 2 Completed
30 enrolled
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
Phase 2 Completed
49 enrolled 4 charts
Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant
Phase NA Completed
40 enrolled 8 charts
Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
Phase 1 Completed
20 enrolled
GVHD
Phase NA Completed
20 enrolled 27 charts